DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding DiaMedica Therapeutics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 43 | 34 | −9 |
| Shares | 3.79M | 2.81M | −980.0K (−25.9%) |
| Value | $16.9M | $11.2M | −$5.66M (−33.5%) |
New holders (5)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 74,280 | $298.0K | 0.00% |
| Jump Financial, LLC | 18,300 | $73.0K | 0.01% |
| Shay Capital LLC | 10,000 | $40.0K | 0.01% |
| Massmutual Trust Co FSB | 4,824 | $19.0K | 0.00% |
| Gerber Kawasaki Wealth & Investment Management | 197 | $0 | 0.00% |
Sold out (14)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Corriente Advisors, LLC | 203,641 | $906.0K |
| Bank of Montreal | 142,846 | $694.0K |
| Renaissance Technologies LLC | 94,100 | $419.0K |
| Two Sigma Securities, LLC | 30,511 | $136.0K |
| Millennium Management LLC | 20,690 | $92.0K |
| UBS Group AG | 20,715 | $92.0K |
| Wolverine Trading, LLC | 18,734 | $89.0K |
| Trexquant Investment LP | 17,019 | $76.0K |
| Dimensional Fund Advisors LP | 14,074 | $63.0K |
| JPMorgan Chase & Co | 8,299 | $37.0K |
| Credential Qtrade Securities Inc. | 769 | $3.42K |
| Bank of America Corp | 145 | $1.00K |
| Federated Hermes, Inc. | 285 | $1.00K |
| O'Shaughnessy Asset Management, LLC | 45 | $0 |